Drug reaction with eosinophilia and systemic symptoms (DRESS) following imatinib therapy;DRESS (Drug reaction with eosinophilia and systemic symptoms) après traitement par imatinib (Glivec™)

Annales de Dermatologie et de Venereologie

Volumn 133, Issue 8-9, 2006, Pages 686-688

  Le Nouail, P ^a   Viseux, V ^a   Chaby, G ^a   Billet, A ^a   Denoeux, J P ^a   Lok, C ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; HYDROXYUREA; IMATINIB; OXACILLIN; PRISTINAMYCIN; STEROID;

AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BLOOD CULTURE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CLINICAL EXAMINATION; CLINICAL FEATURE; DRUG ERUPTION; DRUG FEVER; DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOM; DRUG SUBSTITUTION; EOSINOPHIL; EOSINOPHILIA; FACE EDEMA; FEMALE; HUMAN; HYPEREOSINOPHILIA; LABORATORY DIAGNOSIS; LABORATORY TEST; LOW DRUG DOSE; LYMPHADENOPATHY; MACULOPAPULAR RASH; PRURITUS; SEPTICEMIA; SKIN MANIFESTATION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STEROID THERAPY; SYSTEMIC DISEASE;

EID: 33748745838     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0151-9638(06)70992-9     Document Type: Article

References (20)

1. Guilhot F. Indications for imatinib mesylate therapy and clinical management. Oncologist 2004;9:271-81.
2. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg 1996;15:250-7.
3. Begon E, Roujeau JC. Syndrome d'hypersensibilité médicamenteuse ou DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms). Ann Dermatol Venereol 2004;131:293-7.
4. Bégaud B, Evreux JC, Jouglard J, Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments. Therapie 1985;40:111-8.
5. Cordel N, Lenormand B, Courville P, Joly P. Étude de la clonalité des lymphocytes cutanés et sanguins au cours du syndrome d'hypersensibilité médicamenteuse chez six malades. Ann Dermatol Venereol 2004;131:1059-61.
6. Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 1998;134:1108-12.
7. Descamps V, Mahe E, Houhou N, Abramowitz L, Rozenberg F, Ranger-Rogez S, et al. Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection. Br J Dermatol 2003;148:1032-4.
8. Arakawa M, Kakuto Y, Ichikawa K, Chiba J, Tabata N, Sasaki Y. Allopurinol hypersensitivity syndrome associated with systemic cytomegalovirus infection and systemic bacteremia. Intern Med 2001;40:331-5.
9. g. Regnier S, Descamps V, Boui M, Lebrun-Vignes B, Descamps D, Grossin M, et al. Primo-infection à Parvovirus B19 mimant un syndrome d'hypersensibilité médicamenteuse. Ann Dermatol Venereol 2000;127:505-6.
10. Ly K, Le Brun V, Sparsa A, Rogez S, Cendras J, Rhaim K, et al. DRESS syndrome induit par venlafaxine (Effexor™) associé à une réactivation du virus varicelle-zona. Ann Dermatol Venereol 2004;131:1s248.
11. Floret D. Aspects cliniques des syndromes toxiniques streptococciques et staphylococciques. Arch Pediatr 2001;8:762-8.
12. Valeyrie L, Bastuji-Garin S, Revuz J, Bachot N, Wechsler J, Berthaud P, et al. Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: a prospective study of 54 patients. J Am Acad Dermatol 2003;48:201-6.
13. Drummond A, Micallef-Eynaud P, Douglas WS, Murphy JA, Hay I, Holyoake TL, et al. A spectrum of skin reactions caused by the tyrosine kinase inhibitor imatinib mesylate (STI 571, GLIVEC). Br J Haematol 2003;120:911-3.
14. Roux C, Boisseau-Garsaud AM, Saint-Cyr I, Hélénon R, Quist D, Delaunay C. Toxidermie lichénoïde à l'imatinib (Glivec™). Ann Dermatol Venereol 2004;131:571-3.
15. Fardet L, Bourrat E, Kérob D, Rybojad M, Morel P, Lebbé C. Hémorragies sous unguéales induites par l'imatinib (Glivec™). Ann Dermatol Venereol 2004;131:1S246.
16. Robert C, Spatz A, Faivre S, Armand JP, Raymond E. Tyrosine kinase inhibition and grey Hair. Lancet 2003;361:1056.
17. Brouard MC, Prins C, Mach-Pascual S, Saurat JH. Acute generalized exanthematous pustulosis associated with STI571 in a patient with chronic myeloid leukaemia. Dermatology 2001;203:57-9.
18. Hsiao LT, Chung HM, Lin JT, Chiou TJ, Liu JH, Fan FS, et al. Stevens-Johnson syndrome after treatment with STI571: a case report. Br J Haematol 2002;117:620-2.
19. Hamm M, Touraud JP, Mannone L, Klisnick J, Ponnelle T, Lambert D. Vasculite purpurique induite par l'imatinib. Ann Dermatol Venereol 2003;130:765-7.
20. Clark SH, Duvic M, Prietol VG. Mycosis fungoides-like reaction in a patient treated with Gleevec. J Cutan Pathol 2003;30:279-81.